HCM and heart failure: is your patient at risk?
Video navigation menu
- Is it common? 0:24
- Should we care? 3:09
- Relevance of LVEF 4:34
- Imaging 6:06
- Biomarkers 7:35
- Summary 8:11
Which HCM phenotype has the highest risk of heart failure?
- A. Nonobstructive
- B. Provocable obstruction
- C. Rest obstruction
- D. There is no increased risk of HF in HCM
This lecture by Rudolf de Boer was part of the EBAC-accredited symposium "Hypertrophic cardiomyopathy and heart failure: exploring new options" at ESC Heart Failure in Prague, Czech Republic.
Rudolf de Boer is Chair and Professor of Cardiology at the Erasmus MC, Rotterdam, the Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Bristol Myers Squibb.